India Life Sciences Tools Market is Growing Due to Demand for Next-Generation Sequencing Equipment

According to Markets and Data Research report, “India Life Sciences Tools Market Assessment, Opportunities and Forecast, FY2017-FY2031”, the India life sciences tools market was estimated at USD 14.44 billion in FY2023 and is anticipated to reach 33.76 billion by FY2031, growing at a CAGR of 11.22% during the forecast period. India life sciences tools market continue to grow due to factors such as technological advancements, especially in the areas of biotechnology and genetic research, which drive innovation and encourage quantum leap in the market.

Through several initiatives, the Indian government actively supports R&D projects in the life sciences industry. It includes tax breaks, programs to advance the biotechnology and biopharma sectors, and production linked incentive scheme for the manufacturing of medical devices. The increasing prevalence of chronic diseases is driving the need for advanced services, instruments, and cutting-edge products in the life sciences industry. Furthermore, the increasing prevalence of cell bio-technology and the use of next-generation sequencing products are indicative of the industry's transition to increasingly complex and accurate techniques. Furthermore, the biopharmaceutical industry is growing the need for life sciences instruments emphasizing the industry's shift towards more specialized and customized solutions to address the public's expanding healthcare needs. All these elements work together to support the biosciences industry's rapid growth and development in India.

Spread through 153 pages, the "India Life Sciences Tools Market" report includes an in-depth TOC, over 16 market data figures, latest market developments, key drivers and opportunities, and a thorough study of major company profiles. Moreover, the report offers strategic recommendations, pricing analysis, market share analysis, and value chain analysis in detail.

Key Takeaways:

1. In India, the incorporation of bioinformatics fosters innovation in genomics, proteomics, and personalized medicine research by improving data processing, interpretation, and modelling.

2. In India, there is a growing need for environmentally friendly life sciences tools which promote sustainability using biodegradable materials and energy-saving devices.

3. Point-of-care testing devices are becoming more popular in India to provide quick diagnosis outside of labs for rural locations, emergencies, and at-home medical requirements.

4. Artificial Intelligence (AI) is revolutionizing drug discovery, personalized healthcare, and data analysis in India life sciences tools. It optimizes research efficiency and treatment tactics.

India life sciences tools market is segmented in the following categories:

By Type: Instruments, Consumables, and Services

By Technology: Genomics, Proteomics, Cell Biology Technology, Lab Supplies, and Others

By Product: Cell Culture Systems and 3D Cell Culture, Liquid Chromatography, Mass Spectrometry, Flow Cytometry, Cloning and Genome Engineering, Microscopy, Next Generation Sequencing, PCR & qPCR, Nucleic Acid Preparation, Nucleic Acid Microarray, Sanger Sequencing, Transfection Devices and Gene Delivery Technologies, Nuclear Magnetic Resonance (NMR), and Others

By End-user: Healthcare, Government and Academic Institutions, Biopharmaceutical Company, Industrial Applications, and Others

By Region: North, South, East, and West and Central

There is an increasing demand for instruments used in the life science tools market in India. The changing dynamics of the healthcare sector in the country is combined with the increasing desire for creative solutions in biological investigations and the rising focus on research and development activities, performing as the major drivers for growth in the market. Instruments play a vital role in the promotion of advancements in India life sciences tools market. Instruments such as microscopes, spectrometers, gene editing technologies, and DNA sequencing platforms are needed to suffice the growing demand for advanced life sciences instruments.

For instance, in July 2023, Becton Dickinson and Co announced a novel cell sorting instrument called the BD FACSDiscover S8. This device incorporates two revolutionary technologies: BD Cell View Image Technology and BD SpectralFX Technology. These new-age technologies empower researchers to unveil intricate details about cells that were previously concealed in conventional flow cytometry experiments, thereby enhancing the depth of information obtained from cell analysis.

The increased funding for research in cell biology by the National Institute of Health and the growing significance of cell biology in drug discovery are the reasons behind the dominance of cell biology technology in the life sciences tools market in India. The rising use of cell-based tests in the development of drugs has occurred due to innovations in flow cytometry and liquid handling. Furthermore, partnerships between leading companies to create state-of-the-art biomarkers and enhance stem cell production quality control are anticipated to propel the expansion of the cell biology technology sector in the Indian market.

Leading bio-incubator in Hyderabad, Atal Incubation Centre - CCMB, teamed up with Thermo Fisher Scientific Inc., in April 2024, to outfit its Center for Innovation with cutting-edge equipment. It gave start-up scientists an access to platforms such as CellInsight CX7, KingFisher Flex, and EVOS M7000. The goal of this cooperation is to assist workflows in molecular, protein, and cell biology by fostering innovation in research, drug discovery, and assay development.

The market for life sciences instruments is changing, and Indian colleges and institutions are significantly changing the market scenario. With the recent licencing of an innovative technique by an American genetic medicine company, Banaras Hindu University has proven its prowess in DNA alteration and gene editing. The partnership highlights the organization's contribution to the advancement of genetic research. Concurrently, the Indian Institute of Technology Guwahati is about to launch the nation's first-ever Centre of Advanced Research on Diagnostics in Cancer (C-CARD). Modern next-generation sequencing (NGS) and whole genome sequencing (WGS) equipment will be housed in the center with the goal of identifying cancer's underlying genetic causes which are unique to India. For instance, in March 2023, Illumina Inc. partnered with French firm GenoScreen to develop a new product. The product integrates Illumina products with the GenoScreen Deeplex Myc-Tuberculosis assay, a targeted Next-Generation Sequencing test designed to swiftly and comprehensively identify anti-TB drug resistance. Presently, conventional testing methods rely on culturing, which takes up to two months for showing results, and conventional molecular assays which have limitations in identifying drug resistance.

Major Companies Operating in India Life Sciences Tools Market Include:

1. Becton Dickinson India Pvt Ltd
2. Agilent Technologies India Pvt Ltd
3. Illumina Inc.
4. Thermo Fisher Scientific Inc.
5. Roche Products India Pvt Ltd
6. Bio-Rad Laboratories India Pvt Ltd
7. Merck Life Science Pvt Ltd
8. Wipro Ge Healthcare Pvt Ltd
9. Bruker India Scientific Pvt Ltd
10. Qiagen India Pvt Ltd
11. DHR Holding India Pvt Ltd
12. Abbott India Pvt Ltd
13. Shimadzu India Pvt Ltd
14. Hitachi High-tech India Pvt Ltd
15. Oxford Instruments India Pvt Ltd
16. Carl Zeiss India Pvt Ltd

Download Free Sample Report

To increase their market share and take advantage of India's expanding potential, foreign life sciences corporations are partnering with domestic Indian businesses. They can take advantage of India's sizable and expanding market, highly skilled labor pool, and advantageous regulatory framework through strategic partnerships. International partners provide their worldwide reach, technology, and resources, while local businesses such as Sai Life Sciences, Bharat Biotech, and others add expertise in certain areas such as contract research, development, and manufacturing. Through these collaborations, both sides can boost efficiency, innovate more quickly, and become more competitive in the global market.

Nicoya announced in February 2024 that Medispec is appointed as its sole distributor in India. In terms of Nicoya's dedication to offer research solutions to the scientific community worldwide, the strategic relationship represents a major turning point. Modern Alto and OpenSPR systems from Nicoya are well known for expediting biomolecular interaction investigations and lead screening in the drug discovery process. 

“India Life Sciences Tools Market Assessment, Opportunities and Forecast, FY2017-FY2031F”, evaluates the future growth potential of India life sciences tools market and provides statistics and information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision-makers to make investment decisions for their organizations more strategically. Moreover, the report identifies and examines the emerging trends along with key drivers, challenges, and opportunities in the India life sciences tools market.

Contact
Mr. Vivek Gupta
5741 Cleveland street, 
Suite 120, VA beach, VA, USA 23462
Tel: +1 (757) 343-3258
Email: info@marketsandata.com
Website: https://www.marketsandata.com/